MoneyWorks4Me

Shree Ganesh Remedies Ltd (SGRL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540737 NSE: SGRL Pharmaceuticals & Drugs | Small Cap | Shree Ganesh Remed. Share Price

₹718.40 14.60 (2.07%)

As on 23-Sep'26 12:55

Shree Ganesh Remedies Ltd (SGRL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540737 NSE: SGRL Pharmaceuticals & Drugs | Small Cap | Shree Ganesh Remed. Share Price

₹718.40 14.60 (2.07%)

As on 23-Sep'26 12:55

Key Metrics
Valuation Multiples
Market Cap
₹904 Cr.
Current Price
₹718.4
52-Week Low / High
₹381 / 759
TTM EPS
₹12
TTM Sales
₹99 Cr.
Book Value per Share
₹127.8
P/E Ratio
58.54
Higher than its 5-year historical median
Industry PE
54.8
Price to Book (P/B)
5.51
In line with its 5-year historical median
Price to Sales (P/S)
9.13
Higher than its 5-year historical median
EV/EBITDA
26.78
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
11.53%
Outperforms industry median
Return on Capital Employed (ROCE)
14.63%
Outperforms industry median
Return on Assets (ROA)
8.61%
Operating Profit Margin
32.1%
Net Profit Margin
16.25%
Gross Profit Margin
31.2%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
0.64%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-10.69%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
-23.02%
Asset Quality
Promoter Holding
72.84%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹151 Cr.
Equity
₹12.8 Cr.
Face Value
₹10
All Time Low / High
₹22.07 / 950.05

Shree Ganesh Remedies stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Somewhat Good

Valuation

Somewhat Overvalued

Price Trend

Weak
Q.1 Is Shree Ganesh Remedies Ltd a good quality company?
Shree Ganesh Remedies Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Shree Ganesh Remedies Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Shree Ganesh Remedies Ltd vs industry peers?
Shree Ganesh Remedies Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Shree Ganesh Remedies Ltd?
Promoters hold 72.84% of the Shree Ganesh Remedies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Shree Ganesh Remedies Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 16.43% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Shree Ganesh Remedies Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % 26.2%27.7%27%32.6%27.5%32.5%22.5%27.8%19.5%14.6%-
Value Creation
Index
0.91.00.91.31.01.30.61.00.40.0-

Growth Parameters

Sales 19.927.335.358.449.171.391.412610910999
Sales YoY Gr.-37.3%29.5%65.5%-16%45.3%28.2%37.8%-13.7%0.6%-
Adj EPS 2.834.76.77.59.612.419.51713.612
YoY Gr.-5.6%57.7%41.9%11.9%27.3%29.9%56.6%-12.4%-20.1%-
BVPS (₹) 18.623.72834.841.450.969.795.1113.1127127.9
Adj Net
Profit
2.53.65.78.19.111.61626.621.917.515
Cash Flow from Ops. 0-0.9-5.23.93.313.417.130.530.723.8-
Debt/CF from Ops. 0-2.6-0.10.60.101.91.21.31.3-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 20.9%17.4%6.2%0.6%
Adj EPS 19%12.6%3.1%-20.1%
BVPS23.8%25.2%22.1%12.3%
Share Price - 16.4% 12% 32.8%

Key Financial Parameters

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity %
16.616.118.321.419.720.721.525.416.411.39.4
Op. Profit
Mgn %
20.51924.818.727.825.226.933.236.132.131.4
Net Profit
Mgn %
12.713.316.213.918.516.217.521.120.21615.6
Debt to
Equity
00.100.1000.40.30.30.2-
Working Cap
Days
223207200153224194197164209226121
Cash Conv.
Cycle
13497968812593908311313191

Valuation of Shree Ganesh Remed. - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'19Mar'20Mar'24Mar'25Mar'26
Sales3564126109109
Operating Expenses + 2752846974
Manufacturing Costs12111514
Material Costs1838573642
Employee Cost 2381011
Other Costs 58787
Operating Profit 913423935
Operating Profit Margin (%) 24.8%19.6%33.2%36.1%32.0%
Other Income + 14343
Exceptional Items 00000
Interest 01124
Depreciation 1261010
Profit Before Tax 914383124
Tax 231086
Profit After Tax 610282318
PAT Margin (%) 17.7%16.4%22.3%21.2%16.3%
Adjusted EPS (₹)5.28.721.918.013.8
Dividend Payout Ratio (%)18%12.90%0%0%0%
PARTICULARSMar'19Mar'20Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 3442122145163
Share Capital 99131313
Reserves 2533109132150
Debt +14302921
Long Term Debt02292921
Short Term Debt02100
Minority Interest00000
Trade Payables45869
Others Liabilities 34181919
Total Liabilities 4155178200213

Fixed Assets

Net Fixed Assets +14208195105
Gross Block2129105128148
Accumulated Depreciation79253343
CWIP 0017913
Investments 4351813
Inventories76252224
Trade Receivables1018202233
Cash Equivalents 12161013
Others Assets 66142413
Total Assets 4155178200213
PARTICULARSMar'19Mar'20Mar'24Mar'25Mar'26
Cash Flow From Operating Activity + -55303124
PBT 914383124
Adjustment -0-461112
Changes in Working Capital -14-5-5-2-7
Tax Paid 00-8-10-5
Cash Flow From Investing Activity + -0-3-33-36-10
Capex -0-0-31-23-17
Net Investments 0-3-2-137
Others 00000
Cash Flow From Financing Activity + -0-010-1-12
Net Proceeds from Shares 00700
Net Proceeds from Borrowing 00000
Interest Paid 00-1-2-4
Dividend Paid 00-100
Others -0-041-8
Net Cash Flow -517-62
PARTICULARSMar'19Mar'20Mar'24Mar'25Mar'26
Ratios
ROE (%)18.4327.5534.2217.2611.53
ROCE (%)25.6634.7937.8119.5314.63
Asset Turnover Ratio0.851.331.110.590.54
PAT to CFO Conversion(x)-0.830.51.071.351.33
Working Capital Days
Receivable Days100.5078.4053.8069.8090.50
Inventory Days67.3036.8044.307776
Payable Days76.9040.5040.407267.20

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Shree Ganesh Remedies Ltd FAQs

The current trading price of Shree Ganesh Remed. on 23-Sep-2026 12:55 is ₹718.4.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Sep-2026 the market cap of Shree Ganesh Remed. stood at ₹903.5 Cr

The latest P/E ratio of Shree Ganesh Remed. as of 22-Sep-2026 is 58.49.

The latest P/B ratio of Shree Ganesh Remed. as of 22-Sep-2026 is 5.50.

The 52-week high of Shree Ganesh Remed. is ₹759.0 and the 52-week low is ₹381.1.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shree Ganesh Remed. is ₹98.98 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Shree Ganesh Remedies Ltd is a average quality company.

The key valuation ratios of Shree Ganesh Remedies Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shree Ganesh Remedies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Shree Ganesh Remedies Ltd

No data to display
You have 46 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now